PROSION
Financial Services · Biotechnology
Overview
PROSION Therapeutics is a drug development company that utilises cutting-edge technology to unlock so far undruggable targets and address highly unmet medical needs.
Funding and backers
Latest round
Venture round
Sep 2023 · 3 yr ago
Backers
1
Freigeist Capital
The money's age
Long since its last round
37 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2023 | — | — | handelsregister.de |
| Venture round | May 2022 | — | — | handelsregister.de |
Registers and programsofficial lists and records that name the company
| Legal entity | PROSION GmbH | its site |
| Registered | 10 Aug 2020 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs AbInitio Bio
backs Babylon
backs Wayfinder Biosciences
backs Babylon
backs Babylon
backs Babylon
Similar startupsby what they do, their industry and backers
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
Psylink is a biotechnology company offering a novel solution to psychedelic drug development.
Wayfinder Biosciences develops RNA-targeting small molecules for undruggable targets.
Regor combines a cutting-edge drug discovery engine with target validation and optimization for preclinical candidates in metabolism…
Babylon is a drug development company pursuing a transformational treatment for Alzheimer’s. Meet our team and explore how we discover…
Weatherden is a global drug development consultancy helping biotech and pharma realize the full potential of their science and investment.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Freigeist CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
PROSION Therapeutics
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for PROSION Therapeutics reflects the research output of authors from PROSION Therapeutics who published articles in the 145 journals incl
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cologne
Germany
HQ